Back to Search

THOMAS ABSHIRE, MD

MD

Pediatric Hematology & Oncology Physician

NPI: 1730249681Individual

Specialties, Licenses & Credentials

Pediatric Hematology & Oncology PhysicianPrimary

Pediatrics — Pediatric Hematology-Oncology

Code: 2080P0207X

54405(WI)

Research & Publications (20)

Inhibitors of factor VIII in black patients with hemophilia.
PMID 19369668·N Engl J Med·2009
8-other
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII.
PMID 19473411·Haemophilia·2009
8-other
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.
PMID 18937333·Pediatr Blood Cancer·2009
3-trial
Diagnosis of type 1 VWD: can the clinical history trump laboratory findings?
PMID 19006252·Pediatr Blood Cancer·2009
8-other
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project.
PMID 19637999·Haemophilia·2009
8-other
Association of Bacillus anthracis capsule with lethal toxin during experimental infection.
PMID 19064632·Infect Immun·2009
7-preclinical
Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.
PMID 19141155·Haemophilia·2008
6-review
Recombinant tissue plasminogen activator may reduce frequency of central venous access device infection in hemophilia patients undergoing immune tolerance therapy.
PMID 17143876·Pediatr Blood Cancer·2008
5-case
Childhood ITP: can we venture below 20 000?
PMID 18988870·Blood·2008
8-other
Safety update on recombinant factor VIIa in the treatment of congenital and acquired hemophilia.
PMID 18544421·Semin Hematol·2008
6-review
Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors.
PMID 18684126·Haemophilia·2008
6-review
Activity of the Bacillus anthracis 20 kDa protective antigen component.
PMID 18808698·BMC Infect Dis·2008
8-other
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
PMID 17687129·N Engl J Med·2007
4-observational
Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates.
PMID 17002659·J Thromb Haemost·2006
8-other
The von Willebrand disease prophylaxis network (vWD PN): exploring a treatment concept.
PMID 16545435·Thromb Res·2006
4-observational
Current issues in prophylactic therapy for persons with hemophilia.
PMID 16549891·Acta Haematol·2006
6-review
Prophylaxis and von Willebrand's disease (vWD).
PMID 16580053·Thromb Res·2006
6-review
Inhibitor development, immune tolerance and prophylaxis in haemophilia A--the need for an evidence-based approach.
PMID 16834746·Haemophilia·2006
8-other
Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study.
PMID 16856890·Br J Haematol·2006
4-observational
The von Willebrand disease prophylaxis network: exploring a treatment concept.
PMID 17059476·J Thromb Haemost·2006
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
9000 W WISCONSIN AVE
MILWAUKEE, WI 53226

Location

Practice Location

9000 W WISCONSIN AVE, MILWAUKEE, WI
(414) 266-2420

Quick Facts

NPI
1730249681
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile